Prognostic factors for short-term survival of dogs that experience postattenuation seizures after surgical correction of single congenital extrahepatic portosystemic shunts: 93 cases (2005-2018).
Journal
Veterinary surgery : VS
ISSN: 1532-950X
Titre abrégé: Vet Surg
Pays: United States
ID NLM: 8113214
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
02
10
2018
revised:
03
12
2018
accepted:
26
01
2019
pubmed:
5
4
2020
medline:
18
11
2020
entrez:
5
4
2020
Statut:
ppublish
Résumé
To identify prognostic factors for short-term survival of dogs that experience seizures within 7 days after surgical correction of single congenital extrahepatic portosystemic shunts (cEHPSS). Multi-institutional retrospective study. Ninety-three client-owned dogs. Medical records at 14 veterinary institutions were reviewed to identify dogs that underwent surgical attenuation of a single cEHPSS from January 1, 2005 through February 28, 2018 and experienced postattenuation seizures (PAS) within 7 days postoperatively. Logistic regression analysis was performed to identify factors associated with 1-month survival. Factors investigated included participating institution, signalment, shunt morphology, concurrent/historical conditions, presence of preoperative neurologic signs, presence of preoperative seizures, aspects of preoperative medical management, surgical details including method and degree of shunt attenuation, type of PAS (focal only or generalized ± focal), drugs administered as part of the treatment of PAS, and development of complications during treatment of PAS. Thirty (32.3%) dogs survived to 30 days. Seventy-six (81.7%) dogs experienced generalized PAS. Factors positively associated with short-term survival included having a history of preoperative seizures (P = .004) and development of focal PAS only (P = .0003). Most nonsurvivors were humanely euthanized because of uncontrolled or recurrent seizures. Dogs that experienced PAS that had a history of preoperative seizures and those that experienced focal PAS only had significantly improved short-term survival. The results of this study provide information that will help in the counseling of owners who seek treatment for PAS after surgical correction of cEHPSS. © 2020 The American College of Veterinary Surgeons.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
958-970Informations de copyright
© 2020 The American College of Veterinary Surgeons.
Références
Mathews K, Gofton N. Congenital extrahepatic portosystemic shunt occlusion in the dog: gross observations during surgical correction. J Am Anim Hosp Assoc. 1988;24:387-394.
Matushek KJ, Bjorling D, Mathews K. Generalized motor seizures after portosystemic shunt ligation in dogs: five cases (1981-1988). J Am Vet Med Assoc. 1990;196:2014-2017.
Hardie EM, Kornegay JN, Cullen JM. Status epilepticus after ligation of portosystemic shunts. Vet Surg. 1990;19:412-417. https://doi.org/10.1111/j.1532-950X.1990.tb01224.x.
Komtebedde J, Forsyth SF, Breznock EM, Koblik PD. Intrahepatic portosystemic venous anomaly in the dog: perioperative management and complications. Vet Surg. 1991;20:37-42. https://doi.org/10.1111/j.1532-950X.1991.tb00303.x.
White RN, Burton CA, McEvoy FJ. Surgical treatment of intrahepatic portosystemic shunts in 45 dogs. Vet Rec. 1998;142(14):358-365. https://doi.org/10.1136/vr.142.14.358.
Youmans KR, Hunt GB. Cellophane banding for the gradual attenuation of single extrahepatic portosystemic shunts in eleven dogs. Aust Vet J. 1998;76(8):531-537. https://doi.org/10.1111/j.1751-0813.1998.tb10208.x.
Heldmann ED, Holt E, Brockman DJ, Brown DC, Perkowski SZ. Use of propofol to manage seizure activity after surgical treatment of portosystemic shunts. J Small Anim Pract. 1999;40:590-594. https://doi.org/10.1111/j.1748-5827.1999.tb03029.x.
Hunt GB, Hughes J. Outcomes after extrahepatic portosystemic shunt ligation in 49 dogs. Aust Vet J. 1999;77:303-307. https://doi.org/10.1111/j.1751-0813.1999.tb10268.x.
Tisdall PL, Hunt GB, Youmans KR, Malik R. Neurological dysfunction in dogs following attenuation of congenital extrahepatic portosystemic shunts. J Small Anim Pract. 2000;41(12):539-546. https://doi.org/10.1111/j.1748-5827.2000.tb03150.x.
Yool DA, Kirby BM. Neurological dysfunction in three dogs and one cat following attenuation of intrahepatic portosystemic shunts. J Small Anim Pract. 2002;43:171-176. https://doi.org/10.1111/j.1748-5827.2002.tb00052.x.
Connery NA, McAllister H, Skelly C, et al. Cellophane banding of congenital intrahepatic portosystemic shunts in two Irish wolfhounds. J Small Anim Pract. 2002;4:345-349.
Hurn SD, Edwards GA. Perioperative outcomes after three different single extrahepatic portosystemic shunt attenuation techniques in dogs: partial ligation, complete ligation and ameroid constrictor placement. Aust Vet J. 2003;81(11):666-670. https://doi.org/10.1111/j.1751-0813.2003.tb12532.x.
Kummeling A, Van Sluijs FJ, Rothuizen J. Prognostic implications of the degree of shunt narrowing and of the portal vein diameter in dogs with congenital portosystemic shunts. Vet Surg. 2004;33:17-24. https://doi.org/10.1111/j.1532-950x.2004.04004.x.
Hunt GB, Kummeling A, Tisdall PL, et al. Outcomes of cellophane banding for congenital portosystemic shunts in 106 dogs and 5 cats. Vet Surg. 2004;33:25-31. https://doi.org/10.1111/j.1532-950x.2004.04011.x.
Mehl M, Kyles AE, Hardie EM, et al. Evaluation of ameroid ring constrictors for treatment for single extrahepatic portosystemic shunts in dogs: 168 cases (1995-2001). J Am Vet Med Assoc. 2005;226:2020-2030.
Mehl ML, Hardie AE, Case JB, Kass PH, Zwingenberger A, Gregory CR. Surgical management of left-divisional intrahepatic portosystemic shunts: outcome after partial ligation of, or ameroid ring constrictor placement on, the left hepatic vein in twenty-eight dogs (1995-2005). Vet Surg. 2007;36:21-30. https://doi.org/10.1111/j.1532-950X.2007.00231.x.
Gommeren K, Claeys S, de Rooster H, Hamaide A, Daminet S. Outcome from status epilepticus after portosystemic shunt attenuation in 3 dogs treated with propofol and phenobarbital. J Vet Emerg Crit Care (San Antonio). 2010;20(3):346-351.
Fryer KJ, Levine JM, Peycke LE, Thompson JA, Cohe ND. Incidence of postoperative seizures with and without levetiracetam pretreatment in dogs undergoing portosystemic shunt attenuation. J Vet Intern Med. 2011;25:1379-1384. https://doi.org/10.1111/j.1939-1676.2011.00819.x.
Weisse C, Berent AC, Todd K, Solomon JA, Cope C. Endovascular evaluation and treatment of intrahepatic portosystemic shunts in dogs: 100 cases (2001-2011). J Am Vet Med Assoc. 2014;244(1):78-94.
Heidenreich DC, Giordano P, Kirby BM. Successful treatment of refractory seizures with phenobarbital, propofol, and medetomidine following congenital portosystemic shunt ligation in a dog. J Vet Emerg Crit Care (San Antonio). 2016;26(6):831-836.
Brunson BW, Case JB, Ellison GW, et al. Evaluation of surgical outcome, complications, and mortality in dogs undergoing preoperative computed tomography angiography for diagnosis of an extrahepatic portosystemic shunt: 124 cases (2005-2014). Can Vet J. 2016;57:59-64.
Strickland R, Tivers MS, Adamantos SE, Harcourt-Brown TR, Fowkes RC, Lipscomb VJ. Incidence and risk factors for neurological signs after attenuation of single congenital portosystemic shunts in 253 dogs. Vet Surg. 2018;47(6):745-755. https://doi.org/10.1111/vsu.12925.
Wallace ML, MacPhail CM, Monnet E. Incidence of postoperative neurologic complications in pugs following portosystemic shunt attenuation surgery. J Am Anim Hosp Assoc. 2018;54(1):46-49.
Torisu S, Washizu M, Hasegawa D, Orima H. Sustained severe hypoglycemia during surgery as a genesis of global brain damage in post ligation seizure of congenital portosystemic shunts dogs. J Vet Intern Med. 2006;20(3):753.
Case JB, Marvel SJ, Stiles MC, et al. Outcomes of cellophane banding or percutaneous transvenous coil embolization of canine intrahepatic portosystemic shunts. Vet Surg. 2018;47(S1):O59-O66. https://doi.org/10.1111/vsu.12750.
Mullins RA, Villamil CA, de Rooster H, et al. Effect of prophylactic treatment with levetiracetam on the incidence of postattenuation seizures in dogs undergoing surgical management of single congenital extrahepatic portosystemic shunts. Vet Surg 2019;48(2):164-172. https://doi.org/10.1111/vsu.13141.
Aronson LR, Gacad RC, Kaminskyruss K, Gregory CR, Mullen KD. Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts. Vet Surg. 1997;26:189-194. https://doi.org/10.1111/j.1532-950X.1997.tb01483.x.
Berent TKM, Tobias KM. Hepatic vascular anomalies. In: Johnston SA, Tobias KM, eds. Veterinary Surgery: Small Animal. 2nd ed. St Louis: Elsevier Saunders; 2018:1852-1886.
Moore S, Munana KR, Papich MG, Nettifee-Osborne J. Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses. Am J Vet Res. 2010;71:337-341, DOI: 10.2460/ajvr.71.3.337.